Prosecution Insights
Last updated: April 19, 2026

Ribomic Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18194740 ANTI-CHYMASE APTAMER AND USE FOR SAME ANGELL, JON E 1637 Non-Final OA Apr 03, 2023
17625308 APTAMER FOR TGF-BETA1 AND USE OF SAME GRAY, JESSICA 1682 Non-Final OA Jan 06, 2022

Managing Ribomic Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month